Condition

Granulomatosis With Polyangiitis clinical trials and research

• 6Clinical trials
• 4Countries

Newest Granulomatosis With Polyangiitis clinical trials

All recruiting trials (6)

• TAVNEOS for ENT symptoms in GPA

  This study tests whether adding avacopan to standard care can help people with granulomatosis with polyangiitis who have active ear, nose, and throat symptoms.

  Recruiting at 2 sites Phase 2/3 Hospital for Special Surgery, New York · Edison, New Jersey and 1 other locations · NCT07176546

• Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases

  This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.

  Recruiting at 2 sites Phase 4 University of Sao Paulo General Hospital · São Paulo, São Paulo and 1 other locations · NCT07087912

• Low-dose steroid treatment with standard induction medicines for ANCA-associated vasculitis affecting the kidneys

  This trial will test whether giving only 4 weeks of steroids together with usual induction medicines (cyclophosphamide or rituximab) helps people with ANCA-associated vasculitis that has severely affected the kidneys while reducing steroid-related harms.

  Recruiting Phase 3 Ottawa Hospital Research Institute · Hamilton, Ontario and 1 other locations · NCT06983821

• Obinutuzumab to induce remission in relapsing PR3-ANCA granulomatosis with polyangiitis

  This trial will try obinutuzumab to bring about clinical and blood-marker remission in adults with relapsing PR3-ANCA granulomatosis with polyangiitis.

  Recruiting Phase 2 Assistance Publique - Hôpitaux de Paris · Paris · NCT06940661

• Evaluating the safety and efficacy of Rituximab combined with AB-101 for autoimmune diseases

  This study is testing if combining a new treatment called AB-101 with rituximab can safely help adults with certain autoimmune diseases feel better.

  Recruiting Phase 1 IRIS Research and Development, LLC · Plantation, Florida · NCT06581562

• Salvage treatment options for granulomatosis with polyangiitis

  This trial will test three salvage treatments—rituximab plus a conventional DMARD (preferably methotrexate), tocilizumab, or tofacitinib—to try to induce remission in adults with granulomatosis with polyangiitis who have not responded adequately to standard care.

  Recruiting Phase 3 Assistance Publique - Hôpitaux de Paris · Paris · NCT04871191

Related topics

Quick answers

How many Granulomatosis With Polyangiitis clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in France (2 trials), United States (2 trials), Brazil (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 4: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →